Home-Based System Relieves Cirrhosis Refractory Ascites
|
By HospiMedica International staff writers Posted on 11 Jan 2022 |

Image: An ascites patient with abdominal paracentesis scars (Photo courtesy of iStock)
A novel tunneled peritoneal catheter (PeCa) drainage system provided significant relief for patients with refractory ascites, according to a new study.
The PeCa implant, developed at Hannover Medical School (Germany), is composed of internal shut that lies in the peritoneal cavity, a tunneled section that passes through subcutaneous tissue, and an external port to which drainage bags are connected. To test system efficacy, outcomes in 152 patients with refractory ascites, who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS) and received a PeCa implant, were compared to 71 patients who received standard care, which included repeated large volume paracentesis and albumin.
The results revealed that factors associated with 90-day survival were PeCa implantation, and each point of Model for End-Stage Liver Disease (MELD) score. Hospitalizations were more common in the PeCa group, for reasons that included spontaneous bacterial peritonitis (SBP), hyponatremia, and infections other than SBP. There was no significant difference in mortality between the two groups, but there were trends in the PeCa group towards higher frequency of acute kidney injury (AKI). The study was presented at the American Association for the Study of Liver Diseases annual conference, held online during November 2021.
“Patients with refractory ascites have a very high risk for rehospitalization, AKI, and death. Our data indicate that PeCa could be a valuable new treatment option for patients with refractory ascites and contraindication for TIPS,” said study co-author and presenter Tammo Lambert Tergast, MD. “I think if we can optimize the treatment after discharge, we can also minimize the rehospitalization in these patients. However, the risk for hyponatremia and AKI has to be considered and further explored.”
Refractory ascites occurs when patients no longer respond to medical therapy, a condition that affects over 100,000 patients in Europe and the United States every year, a number that is growing at approximately 10% a year. The primary treatment for ascites is paracentesis, a procedure in which a large bore needle is inserted into the patient's abdomen to remove between 5‐10 liters of ascites that has accumulated over a period of a week or two.
Related Links:
Hannover Medical School
The PeCa implant, developed at Hannover Medical School (Germany), is composed of internal shut that lies in the peritoneal cavity, a tunneled section that passes through subcutaneous tissue, and an external port to which drainage bags are connected. To test system efficacy, outcomes in 152 patients with refractory ascites, who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS) and received a PeCa implant, were compared to 71 patients who received standard care, which included repeated large volume paracentesis and albumin.
The results revealed that factors associated with 90-day survival were PeCa implantation, and each point of Model for End-Stage Liver Disease (MELD) score. Hospitalizations were more common in the PeCa group, for reasons that included spontaneous bacterial peritonitis (SBP), hyponatremia, and infections other than SBP. There was no significant difference in mortality between the two groups, but there were trends in the PeCa group towards higher frequency of acute kidney injury (AKI). The study was presented at the American Association for the Study of Liver Diseases annual conference, held online during November 2021.
“Patients with refractory ascites have a very high risk for rehospitalization, AKI, and death. Our data indicate that PeCa could be a valuable new treatment option for patients with refractory ascites and contraindication for TIPS,” said study co-author and presenter Tammo Lambert Tergast, MD. “I think if we can optimize the treatment after discharge, we can also minimize the rehospitalization in these patients. However, the risk for hyponatremia and AKI has to be considered and further explored.”
Refractory ascites occurs when patients no longer respond to medical therapy, a condition that affects over 100,000 patients in Europe and the United States every year, a number that is growing at approximately 10% a year. The primary treatment for ascites is paracentesis, a procedure in which a large bore needle is inserted into the patient's abdomen to remove between 5‐10 liters of ascites that has accumulated over a period of a week or two.
Related Links:
Hannover Medical School
Latest Patient Care News
- EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
- Virtual Reality Helps Claustrophobic Patients Complete Cardiac PET/CT Scans
- Weighted Blankets Reduce Anxiety in Hospitalized Adults
- Multicenter Study Quantifies Delays in Care for Emergency Department Boarders
- Real-Time Radiation Monitor Supports Safer Fluoroscopy-Guided Procedures
- FDA-Cleared Finger Cuff Device Enables Home Blood Pressure Monitoring
- AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
Channels
Artificial Intelligence
view channelAI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment
Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more
AI-Powered ECG Model Gains FDA Authorization for Emergency Cardiac Assessment
Powerful Medical’s PMcardio Queen of Hearts (ACS AI ECG Model) has received U.S. Food and Drug Administration (FDA) De Novo authorization, announced on September 15, 2026. The model is designed to identify... Read moreCritical Care
view channel
Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease
Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more
Multimodal AI Improves Treatment Response Prediction in Lung Cancer
Immunotherapy has transformed care for advanced non-small cell lung cancer (NSCLC), yet only a minority of patients achieve durable benefit. Clinicians still struggle to predict who will respond, and treatment... Read more
New Approach Helps Identify Materials for More Reliable Wearable Electronics
Wearable health monitors and electronic skin must maintain stable performance while being stretched and bent. Molecular single crystals are promising for such stretchable electronics, yet the microscale... Read more
Scotland Adopts Respiratory Infection Control Guidance Informed by Aerosol Research
Preventing respiratory infection transmission in hospitals remains a core patient and staff safety priority. Many precautions have hinged on the assumption that certain clinical interventions create high-risk... Read moreSurgical Techniques
view channel
Robotic Platform Advances Fetoscopic Treatment of Twin-to-Twin Transfusion Syndrome
Twin-to-twin transfusion syndrome is a life-threatening complication in monochorionic twin pregnancies caused by unbalanced placental blood flow. Definitive treatment requires endoscopic laser coagulation... Read more
Patient-Specific AI Tool Aligns X-Rays With 3D Scans For Surgical Navigation
Minimally invasive procedures rely on real-time X-rays for navigation, but two-dimensional images can obscure the precise location and orientation of instruments inside the body. This uncertainty can prolong... Read more
Hydrogel Dermal Supports Healing of Complex Wounds After Cancer Surgery
Full-thickness skin defects following cancer excision challenge reconstructive teams because grafts and flaps can add donor-site morbidity and prolong recovery. These wounds are common on cosmetically... Read more
FDA Clears Integrated Platform for Real-Time Cardiac Imaging and Catheter Guidance
Catheter-based treatment of cardiac arrhythmias relies on precise, real-time visualization and navigation for safe, accurate therapy delivery. Yet electrophysiology teams often use separate imaging, mapping,... Read moreMedical Imaging
view channel
Structure-Aware AI Aims to Improve Reliability of Medical Image Analysis
Clinicians increasingly rely on medical imaging to guide diagnosis and treatment, but machine learning systems used to analyze these images can be unreliable and difficult to interpret. Small, heterogeneous... Read more
PSMA PET/CT Helps Guide Pre-Biopsy Decisions in Prostate Cancer
Prostate cancer evaluation often begins with prostate-specific antigen (PSA) testing, but elevated levels are not specific to cancer and can lead to unnecessary biopsies. These procedures carry risks of... Read more
AI Models Evaluated for Spotting Ischemic Stroke Lesions on Routine MRI
Rapid detection of ischemic stroke on brain MRI is essential because treatment benefit declines with time. Many centers first acquire contrast-free MRI FLAIR sequences because they are quick and broadly... Read more
Noninvasive MRI Spectroscopy Classifies Pediatric Medulloblastoma Molecular Subgroups
Medulloblastoma, the most common malignant pediatric brain tumor, requires precise molecular classification to guide therapy and predict outcomes. Current subgrouping typically depends on surgical sampling... Read moreHealth IT
view channel
New Tablet Platform Extends Stroke Neurorehabilitation Beyond the Clinic
Continuity and intensity of neurorehabilitation after stroke are critical for functional recovery, but access to ongoing therapy at home often remains limited. Hospitals and outpatient programs therefore... Read more
Smartphone App Improves Blood Pressure Control in Hypertension
Hypertension, or high blood pressure, is a major modifiable driver of cardiovascular, renal, and cerebrovascular morbidity. Despite effective therapies, many adults fail to achieve control, leading to... Read morePoint of Care
view channel
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices
Point-of-care imaging often depends on bulky optical systems that have difficulty visualizing nearly transparent cells and tissues without staining. These limitations can slow diagnosis and restrict use... Read moreBusiness
view channel
Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures
Intuitive (Sunnyvale, CA, USA) announced that it has received CE mark approval for use of the da Vinci SP Single Port surgical system in transvaginal gynecologic procedures, marking the first such indication... Read more







